DEFENDING HEALTHCARE VERTICAL MERGER CHALLENGES AFTER THE RELEASE OF 2023 ANTITRUST MERGER GUIDELINES.
- Published in:
- Houston Journal of Health Law & Policy, 2025, v. 24, n. 2, p. 265
- By:
- Publication type:
- Article
Works matching DE "PHARMACY benefit management"
Results: 98
1
2
DISPENSING WITH ERISA PREEMPTION: REGULATING PHARMACY MARKETS TO ENSURE ACCESS FOR RURAL COMMUNITIES.
- Published in:
- Houston Journal of Health Law & Policy, 2025, v. 24, n. 2, p. 219
- By:
- Publication type:
- Article
3
Rising Drug Costs Drives the Growth of Pharmacy Benefit Managers Exclusion Lists: Are Exclusion Decisions Value-Based?
- Published in:
- 2018
- By:
- Publication type:
- journal article
4
Cooperative partnerships and pricing in the pharmaceutical supply chain.
- Published in:
- International Journal of Production Research, 2019, v. 57, n. 6, p. 1724, doi. 10.1080/00207543.2018.1504249
- By:
- Publication type:
- Article
5
How are we assessing the safety and quality use of medicines used by young people in Australia?
- Published in:
- 2018
- By:
- Publication type:
- journal article
6
CAN HEALTH INSURERS BE LIABLE FOR FACILITATING THE OVERSUPPLY OF PRESCRIPTION OPIOIDS?
- Published in:
- Review of Litigation, 2022, v. 42, n. 1, p. 35
- By:
- Publication type:
- Article
7
Cats at the Christening: Bundled Rebates, Doctrinal Blind Spots, and the Risks of Antitrust Under-Enforcement in the Biologic Pharmaceutical Market.
- Published in:
- University of Memphis Law Review, 2021, v. 51, n. 4, p. 917
- By:
- Publication type:
- Article
8
Lessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity Medications.
- Published in:
- Diabetes Care, 2024, v. 47, n. 8, p. 1246, doi. 10.2337/dci23-0042
- By:
- Publication type:
- Article
9
PHARMACY BENEFIT MANAGERS AND GENERIC PHARMACEUTICALS PRICING CONSPIRACY:UNVEILING LOCK-IN MECHANISMS, STRUCTURAL SHORTCOMINGS AND ANTITRUST EVIDENCE.
- Published in:
- South Dakota Law Review, 2019, v. 64, n. 1, p. 43
- By:
- Publication type:
- Article
10
The Inflation Reduction Act: A Champion for United States Drug Pricing Reform.
- Published in:
- Hinckley Journal of Politics, 2024, v. 25, p. 21
- By:
- Publication type:
- Article
11
Confidence, Perception, and Attitude towards Prescribing Antibiotics among Medical Students and Interns in Jeddah, Saudi Arabia.
- Published in:
- Egyptian Journal of Hospital Medicine, 2018, v. 71, n. 6, p. 3299, doi. 10.12816/0047267
- By:
- Publication type:
- Article
12
The Great Divide: ERISA Integrity versus State Desire to Hold Pharmacy Benefit Managers Accountable for Pharmaceutical Drug Pricing.
- Published in:
- Journal of Corporation Law, 2018, v. 44, n. 1, p. 171
- By:
- Publication type:
- Article
13
legal update.
- Published in:
- Benefits Quarterly, 2024, v. 40, n. 4, p. 43
- Publication type:
- Article
14
Does ERISA Make the Grade?
- Published in:
- Benefits Quarterly, 2024, v. 40, n. 4, p. 38
- By:
- Publication type:
- Article
15
Eighth Circuit Rules Alabama PBM Law Is Preempted by ERISA and Medicare Part D.
- Published in:
- Benefits Quarterly, 2019, v. 35, p. 44
- Publication type:
- Article
16
Pharmacy Benefit Integration: A Connected Approach to Total Medical Cost Savings.
- Published in:
- Benefits Quarterly, 2017, v. 33, n. 2, p. 16
- By:
- Publication type:
- Article
17
Pharmacy and Consumer-Directed Accounts.
- Published in:
- Benefits Quarterly, 2014, v. 30, n. 3, p. 16
- By:
- Publication type:
- Article
18
The Changing Role of Pharmacy Benefit Administration in Managing Chronic Conditions.
- Published in:
- Benefits Quarterly, 2014, v. 30, n. 1, p. 13
- By:
- Publication type:
- Article
19
Drug cost management in pharmacy management based on pharmacoeconomics: Antimicrobial treatment cases.
- Published in:
- Pakistan Journal of Pharmaceutical Sciences, 2017, v. 30, p. 1069
- By:
- Publication type:
- Article
20
PRESIDENT'S perspective.
- Published in:
- Michigan Medicine, 2018, v. 117, n. 3, p. 4
- By:
- Publication type:
- Article
21
TRADING PAIN FOR GAIN: ADDRESSING MISALIGNED INTERESTS IN PRESCRIPTION DRUG BENEFIT ADMINISTRATION.
- Published in:
- University of Michigan Journal of Law Reform, 2022, v. 55, n. 2, p. 423, doi. 10.36646/mjlr.55.2.trading
- By:
- Publication type:
- Article
22
The Case of PBMs.
- Published in:
- Regulation, 2024, v. 47, n. 4, p. 31
- By:
- Publication type:
- Article
23
Introduction.
- Published in:
- Regulation, 2024, v. 47, n. 4, p. 28
- By:
- Publication type:
- Article
24
Eliminating Rebates in Medicare Part D Will Not Reduce Drug Prices.
- Published in:
- Regulation, 2020, v. 43, n. 3, p. 8
- By:
- Publication type:
- Article
25
THE "TROUBLES" WITH PHARMACY BENEFIT MANAGERS.
- Published in:
- Regulation, 2017, v. 40, n. 1, p. 14
- By:
- Publication type:
- Article
26
Using linked electronic medical record-pharmacy data to examine lupus medication adherence: A retrospective cohort study.
- Published in:
- Lupus, 2024, v. 33, n. 12, p. 1299, doi. 10.1177/09612033241280695
- By:
- Publication type:
- Article
27
EXPRESS SCRIPTS, INC. V. DEL. STATE EMPL. BENEFITS COMM.
- Published in:
- Delaware Journal of Corporate Law, 2022, v. 46, n. 2, p. 343
- By:
- Publication type:
- Article
28
An Over-the-Counter Contraceptive Is Approved: The Reproductive Autonomy Imperative.
- Published in:
- JGIM: Journal of General Internal Medicine, 2024, v. 39, n. 8, p. 1499, doi. 10.1007/s11606-024-08749-z
- By:
- Publication type:
- Article
29
Opioid Prescribing and Opioid Risk Mitigation Strategies in the Veterans Health Administration.
- Published in:
- JGIM: Journal of General Internal Medicine, 2020, v. 35, n. 3, p. 927, doi. 10.1007/s11606-020-06258-3
- By:
- Publication type:
- Article
30
Opioid Prescribing and Opioid Risk Mitigation Strategies in the Veterans Health Administration.
- Published in:
- 2020
- By:
- Publication type:
- journal article
31
Pharmacy Benefit Managers and Their Obligations During Serious Prescription Drug Shortages.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 93, n. 2, p. 143, doi. 10.1038/clpt.2012.224
- By:
- Publication type:
- Article
32
Pharmacy Benefit Managers, Rebates, and Drug Prices: Conflicts of Interest in the Market for Prescription Drugs.
- Published in:
- Yale Law & Policy Review, 2020, v. 38, n. 2, p. 360
- By:
- Publication type:
- Article
33
The Journal of Generic Medicines – Editorial March 2025.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
34
SENIOR LIFE INSURANCE IN THE REPUBLIC OF MACEDONIA - STATE AND PERSPECTIVES.
- Published in:
- Horizons Series A, 2014, v. 13, p. 377
- By:
- Publication type:
- Article
35
Senate leaders unveil Rhode Island HEALTH Initiative.
- Published in:
- Rhode Island Medical Journal, 2024, v. 107, n. 4, p. 59
- Publication type:
- Article
36
CAN ANTITRUST LAW CURE THE PHARMACY DESERT PROBLEM IN AMERICA?
- Published in:
- Boston University Law Review, 2024, v. 104, n. 6, p. 1657
- By:
- Publication type:
- Article
37
PHARMACY DESERTS AND ANTITRUST LAW.
- Published in:
- Boston University Law Review, 2024, v. 104, n. 6, p. 1593
- By:
- Publication type:
- Article
38
Physicians Have Trouble Accessing Patient Data.
- Published in:
- Maryland Medicine, 2018, v. 19, n. 4, p. 3
- By:
- Publication type:
- Article
39
PBM Competition in Pharmaceutical Supply Chain: Formulary Design and Drug Pricing.
- Published in:
- Manufacturing & Service Operations Management (M&SOM), 2015, v. 17, n. 4, p. 511, doi. 10.1287/msom.2015.0542
- By:
- Publication type:
- Article
40
A PUSH FOR MORE PBM COST TRANSPARENCY.
- Published in:
- Strategic Finance, 2015, v. 96, n. 9, p. 13
- By:
- Publication type:
- Article
41
Predicting pharmaceutical supply chain disruptions before and during the COVID‐19 pandemic.
- Published in:
- Risk Analysis: An International Journal, 2024, v. 44, n. 12, p. 2797, doi. 10.1111/risa.17453
- By:
- Publication type:
- Article
42
A PRESCRIPTION FOR CALAMITY: WHY THE DEPARTMENT OF LABOR'S PHARMACY BENEFIT MANAGEMENT PROGRAM FALLS SHORT AS A SINGULAR SOLUTION TO THE U.S. OPIOID CRISIS.
- Published in:
- Public Contract Law Journal, 2023, v. 52, n. 2, p. 277
- By:
- Publication type:
- Article
43
Prescription Drug Advisory Boards and Drug Importation--At or Coming to a State Near You?
- Published in:
- Oncology Practice Management, 2024, v. 14, n. 5, p. 5
- By:
- Publication type:
- Article
44
Massive CAA Shake-up Looming for Health Benefits, Empowering Patients.
- Published in:
- Oncology Practice Management, 2023, v. 13, n. 10, p. 1
- By:
- Publication type:
- Article
45
Oncology Community Raising Concerns About Utilization Management, PBMs.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 17
- By:
- Publication type:
- Article
46
What Does the Future Hold for PBMs? Implications for Oncology Practices.
- Published in:
- Oncology Practice Management, 2018, v. 8, n. 10, p. 1
- By:
- Publication type:
- Article
47
Understanding the medicine schedules Part 1: Schedules 0, 1 and 2.
- Published in:
- South African Pharmacist's Assistant, 2014, v. 14, n. 4, p. 2
- By:
- Publication type:
- Article
48
"What about Pharmacy Benefits Managers (PBMs)?".
- Published in:
- Neonatology Today, 2019, v. 14, n. 3, p. 44
- By:
- Publication type:
- Article
49
Identifying Novel Motivation Phase-Specific Cessation Targets for Youth Experiencing Homelessness in the United States.
- Published in:
- Nicotine & Tobacco Research, 2024, v. 26, n. 2, p. 237, doi. 10.1093/ntr/ntad176
- By:
- Publication type:
- Article
50
THE BENEFIT IS IN THE DETAILS: HOW PHARMACY BENEFIT MANAGERS HAVE REAPED PROFITS FROM INSULIN’S INCREASING LIST PRICE AND REMAINED UNSCATHED, UNTIL NOW.
- Published in:
- Widener Law Review, 2023, v. 29, n. 1, p. 97
- By:
- Publication type:
- Article